Skip to main content
editorial
. 2010 Nov 28;2(11):417–424. doi: 10.4329/wjr.v2.i11.417

Table 1.

Studies comparing radiofrequency ablation vs hepatic resection for hepatocellular carcinoma

Author, yr Study type RFA/resection RFA/resection (mean tumor size, cm) RFA vs resection (%) (overall survival) P
Chen, 2006 RCT 90/90 -/- 65.9 vs 64.0 (4-yr) NS
Takayama, 2009 Retrospective 1315/1235 1.6/1.8 95 vs 94 (2-yr) 0.28
Ueno, 2009 Retrospective 123/110 2.0/2.7 63 vs 80 (5-yr) 0.06
Hiraoka, 2008 Retrospective 105/59 -/- 59.3 vs 59.4 (5-yr) NS
Abu-Hilal, 2008 Retrospective 34/34 3.0/3.8 57 vs 56 (5-yr) 0.3
Gnglielmi, 2008 Retrospective 23/33 -/- 45 vs 55 (5-yr) 0.7
Wakai, 2006 Retrospective 64/85 -/- 30 vs 53 (10-yr) 0.012
Ogihara, 2005 Retrospective 40/47 4.6/7.4 39 vs 31 (5-yr) 0.79
Montorsi, 2005 Prospective 58/40 -/- 30 vs 53 (4-yr) 0.018
Vivarelli, 2004 Retrospective 79/79 -/- 33 vs 65 (3-yr) 0.002

RFA: Radiofrequency ablation; RCT: Randomized control trial; NS: Not significant.